500 mg, 15663-27-1
-
Cisplatin
Cayman ChemicalA platinum-containing compound that acts as an alkylating agent; used alone or in combination therapy in the treatment of several types of cancer; inhibits the RecA recombinase of M. tuberculosis (IC50 = 2 µM), blocking protein splicing and cell growth.
-
Cis-Platinum (65% Pt) For Synthesis
MilliporeSigmaCAS No.: 15663-27-1 UN No.: UN3290 Solubility: 2.5 g/l (20°C) Molar Mass: 300.05 g/mol Bulk Density: 850 kg/m3 Density: 3.7 g/cm3 (20°C)
-
Cisplatin
LKT LabsCisplatin is a platinum-based cross-linking agent that exhibits anticancer chemotherapeutic activity. Cisplatin induces crosslinks between guanine bases on DNA; it is clinically used to treat various forms of cancer. In lung cancer cells, cisplatin decreases phosphorylation of PI3K, Akt, and FOXO3a…